Presentation ESC 2017 Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease Presenter: Paul M. Ridker August 27, 2017 REGISTER for free or LOG IN to view this content Clinical Cardiology Clinical Pharma Prevention Coronary ACS/AMI CAD Pharma Plaque Modification Presentation ESC 2017 Up Next Presentation ESC 2017 BIOFLOW V Comparison of Ultrathin Sirolimus-Eluting Bioresorbable Polymer with Thin Everolimus-Eluting Durable Polymer Stents Presenter: David E Kandzari September 13, 2017 More slides + Presentation VIVA 2017 Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan Presenter: Michael Dake September 14, 2017 Presentation Global Geographic Variation in Patient Characteristics in PCI Clinical Trials September 15, 2017 We Recommend
Presentation ESC 2017 BIOFLOW V Comparison of Ultrathin Sirolimus-Eluting Bioresorbable Polymer with Thin Everolimus-Eluting Durable Polymer Stents Presenter: David E Kandzari September 13, 2017
Presentation VIVA 2017 Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan Presenter: Michael Dake September 14, 2017
Presentation Global Geographic Variation in Patient Characteristics in PCI Clinical Trials September 15, 2017